Abstracts tagged "health disparities and rheumatoid arthritis (RA)"

Abstract Number: 1160 • 2019 ACR/ARP Annual Meeting
Clinical Trials in Rheumatoid Arthritis Have Inadequate Racial/Ethnic, Gender and Age Diversity: A Systematic Review
Adrienne Strait¹, Francine Castillo ², Sonam Choden ³, Jing Li ⁴, Evans Whitaker ⁵, Titilola Falasinnu ⁶, Gabriela Schmajuk ³ and Jinoos Yazdany ⁴, ¹UCSF School of Medicine, San Francisco, CA, ²University of California, San Francisco, San Francisco, CA, ³UCSF, SFVAMC Division of Rheumatology, San Francisco, CA, ⁴UCSF Division of Rheumatology, San Francisco, CA, ⁵UCSF Medical Library, San Francisco, CA, ⁶Department of Health Research and Policy, Stanford School of Medicine, Palo Alto, CA
Background/Purpose: Racial/ethnic minorities, women, and the elderly experience a disproportionate burden of disease in Rheumatoid Arthritis (RA), making it particularly important to examine drug therapies…
Abstract Number: 1184 • 2015 ACR/ARHP Annual Meeting
Addressing Medical Non-Adherence from Lack of Finances in an Observed Structured Clinical Exam of Rheumatology Fellows
Irene Blanco¹, Ravi Sutaria², Juliet Aizer³, Anne R. Bass³, Anne Davidson⁴, Theodore R. Fields³, Jane Kang⁵, Leslie Kerr⁶, Deana M. Lazaro⁷, Stephen A. Paget⁸, Michael H. Pillinger⁹ and Jessica Berman¹⁰, ¹Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ²Medicine, North Central Bronx, Bronx, NY, ³Rheumatology, Hospital for Special Surgery, New York, NY, ⁴Autoimmunity and Musculoskeletal Diseases, Feinstein Inst for Med Rsch, Manhasset, NY, ⁵Rheumatology, University of Pennsylvania, Philadelphia, PA, ⁶Associate Professor of Medicine & Geriatrics, Mount Sinai Medical Ctr, New York, NY, ⁷Brooklyn VA, Brooklyn, NY, ⁸Division of Rheumatology, Hospital for Special Surgery, New York, NY, ⁹Medicine/Rheumatology, NYU School of Medicine/NYU Hospital for Joint Diseases, New York, NY, ¹⁰Medicine, New York Presbyterian Weill Cornell Medical College, New York, NY
Background/Purpose: Patients have many reasons for medical non-adherence. Finances often contribute where even the insured may find the cost of medications prohibitively high. In rheumatology,…
Abstract Number: 2634 • 2015 ACR/ARHP Annual Meeting
Associations Between Health Literacy, Ethnicity, Communication Quality and Beliefs about Medicines in Rheumatoid Arthritis
Jennifer Barton^1,2, Patricia P. Katz³, Laura Trupin⁴, Somnath Saha⁵, Dean Schillinger⁶ and Edward H. Yelin⁴, ¹VA Portland Health Care System, Portland, OR, ²Medicine/Rheumatology, Oregon Health & Science University, Portland, OR, ³Rheumatology, UCSF, SF, CA, ⁴University of California, San Francisco, San Francisco, CA, ⁵Medicine, VA Portland Health Care System, Portland, OR, ⁶Medicine, UCSF, San Francisco, CA
Background/Purpose: Vulnerable populations with rheumatoid arthritis (RA) experience poorer health outcomes despite access to current therapies. These disparities may result from limited health literacy, cultural…
Abstract Number: 2022 • 2014 ACR/ARHP Annual Meeting
First Nations Persons Have an Increased Risk of Developing Rheumatoid Arthritis with an Early Onset Age but Are Seen Less Frequently By Rheumatologists: A Population Based Study
Carol A. Hitchon¹, Sazzadul Khan², Brenda Elias³, Hani S. El-Gabalawy⁴, Alan Katz⁵ and Christine A. Peschken¹, ¹Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ²Manitoba Centre for Health Policy and Research, University of Manitoba, Winnipeg, MB, Canada, ³Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁴Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, ⁵University of Manitoba, Winnipeg, MB, Canada
Background/Purpose High global prevalence rates of rheumatoid arthritis (RA) have been reported in First Nations (FN). For our regional population of 1.2 million, health care…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].